European Lung Cancer Working Party Clinical Practice Guidelines. Non-small cell lung cancer: I. Early stages

Authors

  • Costas G. Alexopoulos
  • Thiery Berghmans
  • Marie-Claude Merchier
  • Benoit Colinet
  • Didier Dequanter
  • Anna Efremidis
  • Marie-Chantal Florin
  • Vicente Giner
  • Stefane Jouveshom
  • George Koumakis
  • Jean-Jacques Lafitte
  • Jacques Lecomte
  • Jean Lemaitre
  • Ingrid Louviaux
  • Celine Mascaux
  • Anna-Pascale Meert
  • Vincent Ninane
  • Michel Richez
  • Jean-Paul Sculier
  • Bruno Stach
  • Michael M. Vaslamatzis
  • Patricia Wackenier

DOI:

https://doi.org/10.2015/hc.v1i1.8

Keywords:

guidelines, non-small cell lung cancer, surgery, adjuvant hemotherapy, neoadjuvant chemotherapy

Abstract

The present guidelines on the management of resectable non-small cell lung cancer (NSCLC) were formulated by the (ELCWP) in April 2005. They aim in answering the following eleven questions: 1) Is surgery the best therapy for a potentially resectable cancer? 2) How is complete resection defined? 3) Is systematic lymph node dissection necessary during surgery? 4) What is the role of radiotherapy after complete resec tion? 5) Should adjuvant or neoadjuvant chemotherapy be administered in clinical stages I or II? 6) Should adjuvant chemotherapy be administered in pathological stages I or II? 7) Is adjuvant therapy advisable after complete resection for pathologi cal stage IIIA N2? If yes, of what type: chemotherapy, radiotherapy or chemotradio herapy? 8) What are the indications for surgery after induction treatment, in clinical stages IIIA or IIIB? 9) In clinical stages IIIA or IIIB, is preoperative therapy required and of what type? 10) What type of treatment is indicated after an incomplete surgical resection? 11) What is the best regimen for (neo)adjuvant chemotherapy?

Downloads

Issue

Vol. 1 No. 1 (2006)

Section

Special Topic

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).